Connection
David Wagner to Drug Evaluation, Preclinical
This is a "connection" page, showing publications David Wagner has written about Drug Evaluation, Preclinical.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.153 |
|
|
|
-
Vaitaitis GM, Yussman MG, Wagner DH. A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2019 07 15; 332:8-15.
Score: 0.153